“OBJECTIVE To assess the clinical and urodynamic results of sigmoidocolocystoplasty in patients with neurogenic bladder dysfunction.\n\nMETHODS We retrospectively reviewed 78 augmentation enterocystoplasty cases in our database from 2005 to 2011 to identify 47 patients who had undergone sigmoidocolocystoplasty alone or combined with ureter reimplantation. The indications for surgery and postoperative complications were evaluated.
Renal function preservation, increased postoperative bladder capacity, decreased maximal detrusor BAY 73-4506 manufacturer pressure, and overall patient satisfaction were deemed successful outcomes.\n\nRESULTS The mean follow-up period was 24 months. The mean bladder capacity increased
from 160.6 +/- 128.3 to 468.5 +/- 60.6 mL (P < .001) and the maximal detrusor pressure decreased from 31.1 +/- 26.4 to 10.9 +/- 4.5 cm H2O (P = .002). The serum creatinine level decreased from 270.3 +/- 113.6 to 174.4 +/- 81.3 mu mol/L (P see more = .001). Most patients resolved the urinary incontinence using clean self-intermittent catheterization. The decrease in the mean number of incontinence episodes and pads used daily indicated a marked improvement in patients’ quality of life. Postoperative complications included bowel dysfunction in 5 patients (10.6%), adhesive intestinal obstruction in 4 (8.5%), deteriorating renal function in 3 (6.4%), and vesicoureteral reflux recurrence in 2 patients (4.3%). Nearly all patients expressed satisfaction with the urologic management.\n\nCONCLUSION Our results suggest that sigmoidocolocystoplasty
is safe and effective in treating patients with neurogenic bladder dysfunction. Concomitant ureter reimplantation will be beneficial for patients with a long history of illness. UROLOGY 80: 440-445, 2012. Crown Copyright (c) 2012 Published by Elsevier Inc.”
“Introduction The anatomic localization of reticular pseudodrusen (RPD) has been an important area of research study.\n\nMethods A multimodal imaging analysis was conducted of two patients who were classified as having presumed HIF inhibitor RPD.\n\nResults Analysis of case 1 lends credence to original histopathologic evidence suggesting a choroidal origin of RPD, and analysis of case 2 supports RPD as originating above the RPE.\n\nConclusion This case series demonstrates that RPD may represent a compilation of diseases rather than one distinct clinical entity.”
“Study Design. Combined prospective randomized controlled trial and observational cohort study of degenerative spondylolisthesis (DS) with an as-treated analysis.\n\nObjective. To determine modifiers of the treatment effect (TE) of surgery (the difference between surgical and nonoperative outcomes) for DS using subgroup analysis.\n\nSummary of Background Data.